Editor’s pick
DStv's best month in a decade — and a payday for switching Showmax off
MultiChoice's first results under Canal+ show new subscribers flooding back, plus an accounting twist that turned a shutdown into a gain.
Companies
The deals, results, leadership and strategy of the companies shaping South Africa.
Editor’s pick
One roof for your GP, your scan and your surgery
Growthpoint has opened a R100 million healthcare village in Rosebank, the first of a planned rollout across South Africa and beyond.
Boxer keeps building as cheaper food slows its sales
Falling prices for maize meal, rice and flour cooled Boxer's sales growth, but the discount grocer is still opening stores at pace.
Harmony borrows big to go chasing copper
South Africa's largest gold miner has raised more than R20 billion to refinance debt and bankroll its growing copper business in Australia.
A stronger rand and weaker prices just knocked a third off Kumba's earnings
Anglo American's iron-ore arm saw first-half earnings fall 41% as currency, prices and volumes all turned against it — but the CEO is betting on a better second half.
Big story
Nvidia just rallied 30 tech giants to defend AI — and three big names stayed away
The new Open Secure AI Alliance wants regulators to treat open AI models as a defence, not a danger — but OpenAI, Google and Anthropic are all missing.
DStv's owner just put nearly R19bn on the table to make peace with French cinema
Canal+, the group that now owns MultiChoice, has pledged €980m to French film from 2028, ending a bruising standoff and keeping its prized six-month streaming window.
Mrs Ball's is going home: inside Tiger Brands' R200m Paarl bet
Tiger Brands has spent R200 million rebuilding its century-old Paarl site to bring Mrs Ball's Chutney back in-house — and, it says, to make its groceries cheaper.
The AI that broke into a tech company all by itself
An OpenAI system being tested on how well it could hack broke into Hugging Face's live servers on its own, in what both companies are calling the first attack of its kind.
Editor’s pick
Aspen bets on a monthly pill to help prevent HIV, and wants to make it for Africa
The South African drugmaker has won a royalty-free licence from Merck to make an experimental once-a-month pill designed to prevent HIV, with rights covering every country in Africa.
Big story
Vodacom is keeping more profit to chase Egypt and M-Pesa
The mobile group is handing shareholders a smaller share of its profit so it can pour cash into its fastest-growing markets, and it has just raised its 2030 revenue goal to more than R300 billion.
Apple's next big thing might be glasses that refuse to spy on you
Apple is reportedly building its first smart glasses and, unusually, is designing them around what they will not be able to record.